.jpg)
Gene editing has had a big week in the spotlight. Here’s what’s going on
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: finance
STAT+: Life science investors close nearly $6 billion in new funds
Biotech and life sciences investors continue to draw in new funds even as the biotech…
Sarepta’s disappointing data put the FDA in a difficult spot
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Your Monday morning biotech news roundup
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Regeneron gene therapy improves hearing in child
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro
Want to stay on top of the science and politics driving biotech today? Sign up to get…
The XBI biotech index hit its lowest point since 2018. No one knows what comes next.
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Why AstraZeneca’s CEO is accusing British tabloids of ‘fake news’
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Startup launches with $245 million for twice yearly asthma treatment
A new biotech has raised $245 million to test a new asthma medication that could…
.jpg)
Wegovy doesn’t work for everyone, and no one’s quite sure why
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: In an unusual arrangement, UnitedHealth’s board chair also owns a personal investment firm
Stephen Hemsley, the former CEO of UnitedHealth Group and its current board chair, also owns…
STAT+: Revenue cycle management company Waystar files for IPO
Revenue cycle management company Waystar filed for an initial public offering Monday with the Securities…
As Pfizer slashes revenue projections, Moderna says it “remains comfortable”
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: UnitedHealth’s profit jumps as medical costs come in lower than expected
UnitedHealth Group has made it clear that more people, especially older adults, are seeing their…
Cell and gene therapies could be a safer bet than other drugs
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Life sciences deals on track to hit lowest point since 2017
It’s no secret that biotech industry funding has fallen from its Covid highs. But with…
With Ozempic, Wall Street moves on from a whole other class of medicines
Want to stay on top of the science and politics driving biotech today? Sign up to get…
What’s next in the Kaiser Permanente strike
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: Dana-Farber CEO on Mass General split: Boston needed a dedicated cancer hospital
One of the first items on Laurie Glimcher’s agenda after becoming CEO of the renowned…
Want a biotech buyout? Target cancer
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Kyowa Kirin to acquire Orchard Therapeutics, maker of gene therapy Libmeldy
LONDON — The Japanese firm Kyowa Kirin is acquiring gene therapy maker Orchard Therapeutics in…
STAT+: Failed biotech gives a rare peek inside the tough breaks — and tough choices — that led to its demise
SAN DIEGO — It was spring 2020, and Histogen, a small biotech with big ambitions…
When is a Wall Street disappointment ‘good enough’ for the FDA?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: What will Novo’s VC do with its influx of cash? Don’t expect obesity investments
The Danish pharmaceutical company Novo Nordisk has shepherded all kinds of medical innovation in the…
Kaiser Permanente workers announce an official strike date
You’re reading the web edition of Health Care Inc., STAT’s weekly newsletter following the flow…
STAT+: CommonSpirit’s answer to losing money: get bigger
CommonSpirit Health keeps adding more hospitals — and billions in new debt — even as…
STAT+: Four burning questions about the potential 85,000-worker Kaiser Permanente strike
This week, the Coalition of Kaiser Permanente Unions is negotiating a new national contract with…
STAT+: Patients, doctors press FTC to beef up hospital merger scrutiny
Comments to antitrust regulators lay bare Americans’ anger and disillusionment over consolidation’s effects on all…
STAT+: Walmart may buy concierge Medicare Advantage provider ChenMed. But will it scale?
Walmart seems poised to increase its health care footprint by buying value-based senior care company…
STAT+: Experts fear private equity will pour gas on cardiology’s overuse problem
Coronary stenting is, by some measures, the most overused procedure in hospitals. The problem costs…
STAT+: Nimbus Therapeutics raises $210 million in one of the larger fundraising rounds this year
Seven months after Nimbus Therapeutics sold an experimental autoimmune disease medicine to Takeda Pharmaceuticals for up to…
STAT+: Unicorn down: Following layoffs, Biofourmis CEO quietly departs
A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one…
STAT+: Former Pear Therapeutics executives start new VC firm, with biotech veteran Bob Langer as adviser
Executives from the shuttered digital health company Pear Therapeutics are launching a new VC firm,…
STAT+: Health care CEOs hauled in $4 billion last year as inflation pinched workers, analysis shows
The health care industry didn’t just provide a safe haven for jittery stock investors in…
STAT+: After Optum Health’s lowest profit margin in a decade, UnitedHealth makes changes
Just weeks after the division of UnitedHealth Group that provides care to patients posted its…
STAT+: Hospitals are dialing back on venture capital investing
Hospitals once dove headfirst into venture capital with splashy headlines and attention-grabbing numbers. Now, in…
STAT+: With new acquisitions, Humana and CVS hope to turn members into patients
Both Humana and CVS Health on Wednesday touted plans to aggressively scale their primary care…
STAT+: With profitability in sight, Talkspace is budding into a digital health success story
Virtual mental health company Talkspace on Thursday added to its run of promising earnings reports,…
STAT+: HCA says smaller share of spending going to labor
The chief executive of the country’s biggest hospital chain said Thursday that labor costs are…
STAT+: VC firm starts a new synthetic biology incubator, headed by a former Broad Institute scientist
Venture capital firm RA Capital is starting a new incubator, setting the stage for the…
STAT+: UHS finance chief said company favors patients whose insurance pays more
The country’s largest private psychiatric hospital operator cherry picks patients whose insurance will pay more,…
STAT+: Democrats decry a new health package as too easy on private equity
WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display…
STAT+: Medical device maker Teleflex to acquire urology company Palette Life Sciences for $600 million
Teleflex announced plans on Wednesday to acquire Palette Life Sciences, the maker of a slate…
STAT+: Extensive review finds private equity owners jack up the cost of medical care
Private equity firms are rapidly buying their way into the U.S. health care system, and…
STAT+: States increasingly look to regulate hospital facility fees
Unexpected “facility fees” charged by hospitals have become a growing source of rage for patients,…
STAT+: At Orexo, a ‘turning point’ for everything but digital health
Most everything is looking up for Orexo, the company reported on its second quarter earnings…
STAT+: Westlake Village, a West Coast VC firm, raises $450 million fund
Westlake Village BioPartners, a West Coast biotech venture capital firm founded five years ago by…
STAT+: Demand spikes in seniors, behavioral health care challenge UnitedHealth’s provider arm
UnitedHealth Group’s Optum subsidiary saw a lower operating margin in the second quarter due to…
Big Health acquires Limbix, maker of mental health app for depression in adolescents
Big Health, one of the leading companies producing apps to help treat mental health conditions,…
STAT+: HHS leader to vaccine makers: Set ‘reasonable’ prices for your next round of Covid-19 vaccines
Amid ongoing controversy over the cost of medicines, a key Biden administration official told Covid-19…